✦ LIBER ✦

Biliary excretion of olmesartan, an anigotensin II receptor antagonist, in the rat

✍ Scribed by MOTOE TAKAYANAGI; NAOYO SANO; HAJIME TAKIKAWA

Book ID: 108950253
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 176 KB
Volume: 20
Category: Article
ISSN: 0815-9319
DOI: 10.1111/j.1440-1746.2005.03792.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Disposition of Bismuth in the Rat. II. P

Disposition of Bismuth in the Rat. II. Pharmacokinetics and Biliary Excretion

✍ Niranjan Rao; Stuart Feldman 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 761 KB

In vitro accumulation of thyroid hormone

In vitro accumulation of thyroid hormones by cultured rat hepatocytes and the biliary excretion of iodothyronines in rats treated with a novel histamine H2-receptor antagonist

✍ Alan Poole; Richard B. Jones; Deborah Pritchard; Linda Catto; Thomas Leonard 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 743 KB

In vivo biliary excretion and in vitro c

In vivo biliary excretion and in vitro cellular accumulation of thyroxine by rats or cultured rat hepatocytes treated with a novel histamine H1-receptor antagonist

✍ Alan Poole; Deborah Pritchard; Richard B. Jones; Linda Catto; Thomas Leonard 📂 Article 📅 1990 🏛 Springer-Verlag 🌐 English ⚖ 816 KB

Myocardial electrophysiological properti

Myocardial electrophysiological properties in the presence of an AT1angiotensin II receptor antagonist

✍ M. H. Cox; S. J. O; M. Gasparo; R. Mukherjee; K. W. Hewett; F. G. Spinale 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 896 KB

The pharmacokinetics and metabolism of C

The pharmacokinetics and metabolism of CP-191,166, an angiotensin II receptor antagonist, in rats and dogs

✍ Mary C. Allen; Mark R. Nocerini; Wesley W. Day 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB 👁 1 views

166 is an orally active, non-peptide angiotensin II (AII) receptor antagonist developed for the treatment of hypertension and congestive heart failure (CHF). In this study, the intravenous (iv) and oral (po) single dose pharmacokinetics (PK), oral multiple dose PK and P450-mediated metabolism of 16

An angiotensin II type 1 receptor antago

An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells

✍ Nobuya Kurikawa; Miwa Suga; Shoko Kuroda; Keisuke Yamada; Hirokazu Ishikawa 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 325 KB